← Back to patent-cliff list
克霉唑
Tier C — Watch / tradeClotrimazole
默沙东
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：CYP51A1
Brand：Correcta、Canesten、Gyne-Lotrimin 3、Mycelex Troche、Trivagizole 3、Lotrimin、凯妮汀
Indications (approved)：念珠菌病、外阴阴道念珠菌病、曲霉菌属感染、外耳炎、瘙痒症
Regional status
US
批准上市
1975-02-03
EU
无进展
2008-09-01
China
批准上市
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Clotrimazole?
Approved indications include: 念珠菌病, 外阴阴道念珠菌病, 曲霉菌属感染, 外耳炎, 瘙痒症.
When does the Clotrimazole patent expire?
No public expiry year is available for Clotrimazole yet; this page updates once verified.
How do I get a quote for Clotrimazole intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25